Testing a new heart-failure fluid-removal device in hospitals
Part of Heart & circulation clinical trials.
This trial tests whether the eLym™ device is safe and practical to use in people hospitalized for worsening heart failure with excess fluid. It may help reduce fluid overload while the team checks safety during and after the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be admitted for acute worsening heart failure with signs of fluid overload
- Be receiving IV “water pill” treatment (diuretics) and have had enough dose before admission
- Have kidney function that is not too low (eGFR at least 20)
- Have blood test signs of heart failure (BNP/NT-proBNP above required levels) and higher-than-normal albumin
- Be able to get the device placed within 96 hours and still have fluid overload then
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device that briefly blocks blood flow in a large vein to help your body remove extra fluid, which may improve symptoms like swelling and shortness of breath. It is for people with advanced heart failure who are already in the hospital and need more help with fluid removal.
This trial tests a device designed to safely remove extra fluid from patients hospitalized with worsening heart failure. It may help those who are not responding well to standard water pills (diuretics).
This trial studies a device (the Nephronyx System) used in the hospital to treat worsening heart failure with fluid buildup, especially when diuretics (water pills) aren’t working well. It aims to check the device’s safety and whether it performs as expected to help patients get better.
This trial tests a new way to manage fluid levels in people hospitalized for heart failure. It aims to help doctors adjust treatment to keep you from coming back to the hospital.
This trial tests a new home monitoring device for people with heart failure and leg swelling. The device helps track fluid changes early, so you may be able to avoid hospital stays.
This trial tests if using a wearable monitor (ReDS) to guide fluid removal helps people hospitalized for heart failure. The goal is to find the right amount of fluid to remove so patients feel better and stay out of the hospital.
Hear when a new Heart; Decompensation, Congestive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.